Health economic analysis in favor of Septin9 testing presented by renowned Stanford University researcher at Digestive Disease Week 2011 Patient behavior study underway to demonstrate compliance benefit Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 ...
New York (ots/PRNewswire) - Registering a staggering 84 percent increase in value over the past year, Apple has emerged as the most valuable brand in the world, ending the four-year reign of Google at the top of the table in the sixth annual BrandZ Top 100 Most Valuable Global Brands study. The Apple brand, as ...
Atrium European Real Estate Limited
Contact: Financial Dynamics, London Richard Sunderland / Laurence Jones Phone: +44 (0)20 7831 3113 mailto:richard.sunderland@fd.com Branche: Real Estate ISIN: JE00B3DCF752 WKN: Index: Standard Market Continuous Börsen: Wien / official market ...
Contact: Presse Valerie Weixlbaumer Corporate Communications T: +43/7613/2541-1119 M: +43/664/5416364 valerie.weixlbaumer@miba.com Investoren/Analysten Hannes Moser Vice President Corporate Finance T +43/7613/2541-1471 hannes.moser@miba.com Branche: Industrial Components ISIN: AT0000734835 WKN: 872002 Index: ...
London (ots/PRNewswire) - Lonrho Plc's seafood division, Oceanfresh, has been chosen to provide sixteen product lines to Makro under Makro's private label 'M brand'. Makro (a division of Massmart) is one of the foremost retail chains in South Africa, catering to wholesale shoppers ranging from informal traders and grocery store owners to hoteliers, restaurateurs, ...
Quarter highlighted by completion of enrollment in talactoferrin Phase III FORTIS-M trial and issuance of key U.S. patent for talactoferrin in oncology Contact: Agennix AG Barbara Mueller Manager, Investor Relations & Corporate Communications Tel.: +49 89 8565-2693 ir@agennix.com In the USA: Laurie Doyle Senior Director, Investor Relations & Corporate Communications ...
Leiden, The Netherlands and Seattle (ots/PRNewswire) - ProFibrix B.V., a leader in the development of innovative products that help stop bleeding (hemostasis) after surgery, today announced the successful closing of a series B follow-on financing. In conjunction with the financing and to support the company's next ...
Contact: Contact: Investor Relations cometis AG Ulrich Wiehle Tel.: +49 (0)611 - 205855-11 Fax: +49 (0)611 - 205855-66 E-mail: wiehle@cometis.de Branche: Real Estate ISIN: DE000A0B7EZ7 WKN: A0B7EZ Börsen: Berlin / free trade Stuttgart / free trade Düsseldorf / free trade Frankfurt / regulated dealing/general standard ...
Contact: Moritz M. Gmeiner Director Investor Relations Tel: +43 3136 500-5970 Fax: +43 3136 500-5420 Email: investor@austriamicrosystems.com Branche: Technology ISIN: AT0000920863 WKN: 632638 Börsen: SIX Swiss Exchange / official dealing ...
Order volume of around EUR 290 million Annual production capacity of 116 MW First high-performance modules to be completed by 2014 Contact: Dr. Torsten Knödler Manager Public Relations Tel.: 07344 - 918-8898 E-Mail: torsten.knoedler@centrotherm.de Branche: Energy ISIN: DE000A0JMMN2 WKN: A0JMMN Index: ...
London (ots/PRNewswire) - With excitement around next week's Royal Wedding reaching fever pitch, leading betting firm Paddy Power have reported record levels of betting on the Royal nuptials from people around the world. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/paddypower/48904/ So far almost 5,000 bets have been wagered with the bookmaker on a diverse range of Royal ...
Munich (ots/PRNewswire) - Daiichi Sankyo announced today that it has begun enrolling patients in Europe into a large, multinational phase III trial of tivantinib (ARQ 197). Tivantinib is an investigational small molecule inhibitor of the c-MET receptor tyrosine kinase in final phase of clinical development for the ...
Contact: Investor Relations: Sylwia Milke Phone: +43(0)50100-27402 Fax: +43(0)05100-927402 E-mail: sylwia.milke@simmoag.at www.simmoag.at Corporate Communications: Bosko Skoko Phone: +43(0)50100-27522 Fax: +43(0)05100-927522 E-mail: bosko.skoko@simmoag.at www.simmoag.at Branche: Real Estate ISIN: AT0000652250 WKN: 065225 Index: ATX Prime, IATX Börsen: Wien / ...
Astellas Pharma Europe Limited
London (ots/PRNewswire) - New survey data released today demonstrate that childhood eczema can have a detrimental effect on quality of life not only for the children who live with the disease, but also for their families.[1a] The survey, which was carried out in eight countries across Europe, examines the impact of ...
Amsterdam (ots/PRNewswire) - For a first, the International Debt Collections Handbook includes dedicated reports on China and Hong Kong. The fourth edition has been released today by Atradius Collections. The International Debt Collections Handbook has established itself as an essential tool for businesses making ...
- Schaeffler and Continental jointly acknowledge PWOs exceptional performance - Cooperation to be intensified Contact: Bernd Bartmann (CFO) Phone: +49 7802 / 84-347 Fax: +49 7802 / 84-789 e-Mail: bernd.bartmann@progress-werk.de Branche: Automotive Equipment ISIN: DE0006968001 WKN: 696800 Börsen: Frankfurt / ...
Contact: Barbara Mueller Manager, Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Senior Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG ...
Revenue up by 22.6 percent to EUR 624.2 million EBIT doubles from EUR 37.2 million to EUR 75.4 million Record earnings in Solar Cell & Module segment Revenue budgeted to grow to between EUR 690 million and EUR 710 million in 2011 Dividend proposal of EUR 0.50 plus one-off bonus dividend of EUR 0.20 ...
Astellas Pharma Europe Limited
Tokyo (ots/PRNewswire) - Astellas Pharma Inc. (http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition.(1,2) These data were presented for the ...
Contact: Barbara Mueller Manager, Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Senior Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund Gabriel Phone: +49 (0) 89 210 228 0 ...
Contact: Barbara Mueller Manager, Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Senior Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG ...
London (ots/PRNewswire) - Pharmaceutical R&D productivity is consistently undercounted. Most reports fail to fully count the number of new drugs that reach the market, missing out on billions of dollars of sales generated by R&D investment, an analysis of EvaluatePharma data shows. Most counts of FDA new drug ...
Toulouse, France (ots/PRNewswire) - Derichebourg Atis aéronautique (DERICHEBOURG group) and ETOPS Aviation Services (MWC group) are pleased to announce the signing of a memorandum of understanding (MOU) outlining plans to collaborate on various areas to provide a complete range of aviation services for airlines, OEM's and aircraft leasing companies. Derichebourg Atis ...
Contact: Press: Michael Wudonig, CFA Tel: +49 561 9301-1262 Fax: +49 561 9301-1666 michael.wudonig@k-plus-s.com Investor Relations: Christian Herrmann, CFA Tel: +49 561 9301-1460 Fax: +49 561 9301-2425 christian.herrmann@k-plus-s.com Branche: Chemicals ISIN: DE0007162000 WKN: 716200 Index: DAX, Midcap Market ...
Contact: Investor Realtions: Mag. (FH) Hannes Haider Tel.: 01-21137-12905 hannes.haider@agrana.com Public Relations: Mag. Ulrike Middelhoff Tel.: 01-21137-12084 ulrike.middelhoff@agrana.com Branche: Food ISIN: AT0000603709 WKN: 779535 Index: WBI, ATX Prime Börsen: Berlin / Präsenzhandel Frankfurt / ...
- Group sales up 15.4 % at 1.57 billion - EBITDA margin rises to 21.1 % - Refinancing successfully concluded. Basis set for further profitable growth - EPS 1.13 (+58 %), significantly increased dividend to 0.60 per share Contact: Media Contact: Bernhard Kott phone +49 (0)5531 90-1721 bernhard.kott@symrise.com Investor's Contact Tobias Erfurth phone +49 (0)5531 90-1879 tobias.erfurth@symrise.com Branche: ...
Contact: Lang & Schwarz Broker GmbH Email: analyse@ls-broker.de Branche: Banking ISIN: WKN: - ...
Contact: Moritz M. Gmeiner Director Investor Relations Tel: +43 3136 500-5970 Fax: +43 3136 500-5420 Email: investor@austriamicrosystems.com Branche: Technology ISIN: AT0000920863 WKN: 632638 Börsen: SIX Swiss Exchange / official dealing ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - Bristol-Myers Squibb announced today that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients with evidence of decompensated liver disease. BARACLUDE(r) was already approved in Europe in June 2006 ...